Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Boeing | BOEI | May 30, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | May 30, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | May 30, 2024 | 3.33 | +1.06 |
Brederode S.A. | BREB | May 30, 2024 | 114.60 | +0.53 |
Campine nv | CAMB | May 30, 2024 | 82.00 | -0.61 |
Candela Invest | CAND | May 30, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | May 30, 2024 | 14.98 | +3.45 |
Celyad Oncology SA | CYAD | May 30, 2024 | 0.30 | +1.16 |
Cenergy Holdings | CENER | May 30, 2024 | 8.74 | +2.70 |
Chevron | CHTEX | May 30, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | May 30, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | May 30, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | May 30, 2024 | 60.10 | +1.86 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | May 30, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | May 30, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | May 30, 2024 | 47.06 | +0.99 |
Compagnie du Bois Sauvage S.A. | COMB | May 30, 2024 | 274.00 | +1.48 |
Compagnie d`Entreprises CFE SA | CFEB | May 30, 2024 | 7.61 | +1.20 |
Connect Group | CONN | May 30, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | May 30, 2024 | 0.01 | +11.86 |
Cumulex NV | CLEX | May 30, 2024 | 1.35 | 0.00 |
CURETIS | CURE | May 30, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | May 30, 2024 | 2.57 | 0.00 |
Deme Group N.V. | DEME | May 30, 2024 | 163.60 | -0.85 |
Deutsche Telekom AG | DTEL | May 30, 2024 | 20.00 | 0.00 |
Dexia SA | DEXB | May 30, 2024 | 0.30 | 0.00 |
Diegem KennedyCert | DIEG | May 30, 2024 | 119.00 | -0.83 |
Distri Land Le Certificat Foncier | DISL | May 30, 2024 | 198.00 | 0.00 |
DMS Imaging SA | ALIMG | May 30, 2024 | 0.02 | 0.00 |
DMS Imaging SA | DMSIM | May 30, 2024 | 0.02 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.